Skip to content

Non-contrast Enhanced Cardiac Magnetic Resonance Normal Values and Imaging Protocols

Optimization of Non-contrast Enhanced 1.5 Tesla and 3 Tesla Cardiac Magnetic Resonance Imaging Techniques and Acquisition of Normal Values

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01728597
Acronym
CMR-TECH
Enrollment
200
Registered
2012-11-20
Start date
2011-12-31
Completion date
2027-12-31
Last updated
2025-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

no history of cardiovascular diseases

Brief summary

One of the main problems in cardiac magnetic resonance (MR) investigations is the strong dependence of the achieved image quality on optimal settings of sequence parameters and anatomical and physiological situations and it is well known that the diagnostic impact of cardiac MR investigations crucially depends on the adaption of imaging protocols to patients' state and ability to cooperate. The aim of the present study is the evaluation and optimization of various 1.5 Tesla and 3 Tesla cardiac MR investigation protocols without application of contrast agent as well as the acquisition of normal values for new cardiac MR images techniques: * normal myocardial morphology: T1-, T2- and T2\*-weighted imaging and acquisition of normal values of magnetic relaxation times (sequence- and protocol dependent), * normal cardiac function: systolic and diastolic function (sequence- and protocol dependent), * cardiac anatomy and coronary artery imaging: feasibility to evaluate length, diameter and blood flow (sequence- and protocol dependent), * normal blood flow topologies in the heart and the surrounding great vessels: 2D- and 3D blood flow imaging and evaluation techniques (sequence- and protocol dependent).

Interventions

None listed

Sponsors

Amt der Steiermärkischen Landesregierung, Abteilung 3
CollaboratorUNKNOWN
Medical University of Graz
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* No history of cardiac or pulmonary diseases * ability to give informed consent

Exclusion criteria

* General MR

Design outcomes

Primary

MeasureTime frameDescription
magnetic relaxation timesup to 1 weeksystolic and diastolic T1, T2, T2\* \[ms\], sequence- and protocol dependent
cardiac performanceup to 1 weekejection fraction of cardiac chambers \[%\], sequence- and protocol dependent
cardiac muscle massup to 1 weeksystolic and end-diastolic mass of cardiac chambers \[g\], sequence- and protocol dependent
coronary artery anatomyup to 1 weeklength and diameter \[mm\], sequence-, and protocol dependent
blood flow velocityup to 1 weekmaximum, minimum and average velocity \[cm/s\], sequence-, and protocol dependent
blood flow vorticityup to 1 weeknumber of vortices of blood flow in the heart and surrounding great vessels, sequence and protocol dependent
blood flow timingup to 1 weektime points of characteristic blood flow patterns in the heart and surrounding great vessels in the cardiac cycle \[ms\], sequence-, and protocol dependent
cardiac volumesup to 1 weekvolumes of cardiac chambers in the cardiac cycle \[ml\], sequence- and protocol dependent

Countries

Austria

Contacts

Primary ContactUrsula Reiter, PhD
ursula.reiter@klinikum-graz.at+43-316-385
Backup ContactMichael Fuchsjäger, Prof. Dr.
michael.fuchsjaeger@medunigraz.at+43-316-385

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 22, 2026